All certificates

Certificate library

NAD+ Certificate of Analysis

Current batch
99.29%
APL-NAD500-2608-03
Batches published
3
Measured purity
99.03% – 99.45%
Most recent analysis
17 August 2026

Independent verification

NAD+ is independently tested for bacterial endotoxin by Ozcanium Analytics, an independent Australian laboratory: below 15.0 EU per vial by kinetic chromogenic LAL, analysed 30 August 2026 on lot APL-NAD500-2608-01, verification code OZ-ENDOTX-TAU3.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

Every batch of NAD+ is assayed in our own laboratory before it is released. Purity is measured by HPLC / Mass Spectrometry on the PDA 214 nm channel, reported as main-peak area against every integrated impurity peak. Molecular identity is confirmed by LC-MS across 2 monitored ion channels. The release specification is ≥98.0%. Across the 3 batches published here, measured purity spans 99.03% – 99.45%.

Current batch — APL-NAD500-2608-03

View the full certificate
Document ID
APL-COA-NAD500-2608-03
Net content
503.1 mg
Tested
17 August 2026
Method
HPLC / Mass Spectrometry
TestSpecificationResultStatus
AppearanceWhite/Off-White Lyophilised PowderConformsPASS
Identity (MS)ConfirmedConfirmedPASS
Purity (HPLC)≥98.0%99.29%PASS
Assay (HPLC)98.0–102.0%99.4%PASS
Endotoxins<0.5 EU/mg<0.20 EU/mgPASS
mAUPDA 214 nm025050075010000.50.811.31.51.822.32.5 min 0.9601.180NAD+1.4902.120
Main peak integrated at 99.29% of total area; no single impurity peak exceeds 0.31%.
Peak list — 4 detected
#Time (min)Area% AreaIdentification
10.96015,8400.220—
21.1807,148,88099.290NAD+
31.49022,3200.310—
42.12012,9600.180—
Identity confirmation with SIM
Monitored (m/z)Detected (m/z)Intensity
664664.442.6
686686.421.1

NAD+

Intensity ×107

01233004005006007008009001000 m/z 664686

Every published NAD+ batch

Match the batch number printed on your vial to open its certificate.

BatchSizeTestedPurityCertificate
APL-NAD500-2608-03500 mg17 August 202699.29% View
APL-NAD500-2607-02500 mg15 July 202699.03% View
APL-NAD500-2606-01500 mg15 June 202699.45% View

Earlier batches in full

APL-NAD500-2607-0299.03% purity tested 15 July 2026
Document ID
APL-COA-NAD500-2607-02
Net content
506.8 mg
Tested
15 July 2026
Method
HPLC / Mass Spectrometry
TestSpecificationResultStatus
AppearanceWhite/Off-White Lyophilised PowderConformsPASS
Identity (MS)ConfirmedConfirmedPASS
Purity (HPLC)≥98.0%99.03%PASS
Assay (HPLC)98.0–102.0%98.1%PASS
Endotoxins<0.5 EU/mg<0.15 EU/mgPASS
Peak list — 4 detected
#Time (min)Area% AreaIdentification
10.94323,4360.350—
21.1576,645,36599.030NAD+
31.46225,2230.380—
42.09716,1600.240—
Identity confirmation with SIM
Monitored (m/z)Detected (m/z)Intensity
664664.472.41
686686.421.18

NAD+

Open the APL-NAD500-2607-02 certificate for its chromatogram and spectrum
APL-NAD500-2606-0199.45% purity tested 15 June 2026
Document ID
APL-COA-NAD500-2606-01
Net content
499.5 mg
Tested
15 June 2026
Method
HPLC / Mass Spectrometry
TestSpecificationResultStatus
AppearanceWhite/Off-White Lyophilised PowderConformsPASS
Identity (MS)ConfirmedConfirmedPASS
Purity (HPLC)≥98.0%99.45%PASS
Assay (HPLC)98.0–102.0%98.6%PASS
Endotoxins<0.5 EU/mg<0.10 EU/mgPASS
Peak list — 4 detected
#Time (min)Area% AreaIdentification
10.92913,2570.200—
21.1486,506,86399.450NAD+
31.45313,7320.210—
42.0788,8170.140—
Identity confirmation with SIM
Monitored (m/z)Detected (m/z)Intensity
664664.412.47
686686.41.07

NAD+

Open the APL-NAD500-2606-01 certificate for its chromatogram and spectrum

NAD+ testing — common questions

Is NAD+ third-party tested?
Yes. NAD+ is independently tested for bacterial endotoxin by Ozcanium Analytics, an independent Australian laboratory: below 15.0 EU per vial by kinetic chromogenic LAL, analysed 30 August 2026 on lot APL-NAD500-2608-01, verification code OZ-ENDOTX-TAU3. The report is published on this page as the laboratory issued it, and each verification code can be redeemed in the lab's own portal so the document is confirmed against their records rather than ours. Every batch of NAD+ is also analysed in our own laboratory and published here in full.
What purity is the current batch of NAD+?
Batch APL-NAD500-2608-03, the batch currently shipping, measured 99.29% by HPLC / Mass Spectrometry, tested 17 August 2026. The release specification is ≥98.0%. Across the 3 batches published here, measured purity spans 99.03% – 99.45%.
How do I find the certificate for the NAD+ vial I have?
Each certificate reports one production batch, so match the batch number printed on your vial against the batch history on this page rather than against the compound in general. 3 batches are published: APL-NAD500-2608-03, APL-NAD500-2607-02 and APL-NAD500-2606-01. If the batch you hold isn't listed, email [email protected] with the compound and batch number and we'll send the document.
What is NAD+ tested for?
Every batch is tested for Appearance, Identity (MS), Purity (HPLC), Assay (HPLC) and Endotoxins. Each result is printed beside a fixed specification — ≥98.0% for purity, set as house policy rather than per batch, so a batch cannot pass by having its target moved. Molecular identity is confirmed by LC-MS across 2 monitored ion channels.

NAD+ identification

The registry identifiers printed on every NAD+ certificate. They are what lets the compound be checked against a public record independently of anything we assert about it.

CAS Number
53-84-9
Molecular Formula
C21H27N7O14P2
Molecular Weight
663.43 g/mol
Form
Lyophilised Powder
Presentation
500 mg

Next

View NAD+ in the catalogueWhat third-party tested means, and how to verify it

Holding a NAD+ batch that isn't listed above? Email [email protected] with the batch number and we'll send the document. For the analytical method behind these figures, see our guide to HPLC in peptide quality control.

All products are supplied for laboratory research use only. They are not therapeutic goods and are not for human or veterinary use.